TRP_1170x120_3-8-19

Issue 02-04-2019

Hy-Vee adopts new opioid policy

Hy-Vee adopts new opioid policy

WEST DES MOINES, Iowa — To assist in combatting the national opioid epidemic, Hy-Vee Inc. has implemented a new controlled substance prescription policy. Since January 1, Hy-Vee pharmacies have not allowed a subsequent fill of a Schedule II controlled substance, or a refill of a Schedule III or Scheduled IV controlled substance more than 72

Wider role for CVS’ Sansone

Wider role for CVS’ Sansone

WOONSOCKET, R.I. — CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front-store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone. He had been vice president of merchandising for consumer health care. Sansone’s team will be responsible

WBA joins Microsoft in health care partnership

WBA joins Microsoft in health care partnership

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Microsoft Corp. have teamed up to develop new health care delivery models, technology and retail innovations to advance and improve the future of health care. The companies will combine the power of Microsoft Azure, Microsoft’s cloud and artificial intelligence platform, health care investments, and new retail solutions

Case for DIR reform advanced

Case for DIR reform advanced

ARLINGTON, Va. — The National Association of Chain Drug Stores has submitted extensive and thoroughly documented comments to the Centers for Medicare and Medicaid Services (CMS) in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees — reform that relates directly to reducing patients’ out-of-pocket drug costs. NACDS issued its comments